Delay of generics' license will hurt pharmaceutical sector
Published: 2007-11-02 06:59:00
Updated: 2007-11-02 06:59:00
The government's plan to deny a local pharmaceutical company the license to sell generic drugs for at least two years under the proposed revision of the Pharmaceutical Affairs Law stirred heated debate in a government-private discussion on October 30.
The delay of generics' launching will be a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
